Newsroom

December 05, 2016

Celdara Medical, LLC (Celdara) today announced that it has been recognized as the fastest growing company in the State of New Hampshire by Business NH Magazine. This award is based on 3-year average revenue growth, where Celdara delivered an average 198% growth rate, leading all companies in all categories. This is the 4th consecutive year that Celdara has been ranked in the “Top 10 to Watch.”

Jake Reder, Ph.D., Celdara’s Co-Founder and CEO, commented, “This is a unique honor from the premiere business publication in our State, and an acknowledgement of all the hard work, dedication and passion our team brings to our Mission every day. It is heartening that our focus on delivering hope and health to patients, and their caregivers, can also translate into exceptional financial performance. We are proud of our success to date, and our global networks, pipeline and opportunities have never been stronger. We look forward to increasing our impact on human health in the months and years to come.”

Founded in 2008 by Drs. Jake Reder and Michael Fanger, Celdara is headquartered at the Dartmouth Regional Technology Center (DRTC) in Lebanon, NH. Celdara’s products are therapies and diagnostics, each with the potential to address the deadliest and most difficult diseases, bridging the gaps between invention and clinical impact. From a large pipeline of opportunities, Celdara identifies the most promising innovations and discoveries, then works closely with their inventors, “Transforming Innovation into Medicine.™”

The article appears in the Dec. 2016 issue of Business NH Magazine.

 

About Celdara Medical, LLC

Celdara Medical gives hope and health to patients by transforming academic innovations into medicines with the potential to cure the world’s most challenging diseases. Celdara Medical is a recognized leader with a rich stable of discoveries, developed in concert with premiere research institutions in the US, EU, and beyond. We secure lasting partnerships with inventors and their institutions, and provide the developmental, financial, and business acumen to bridge the gaps between discovery and clinical impact. With robust funding options, operations in greater Boston, NYC, and Washington, DC, growing affiliates in Seattle and Indianapolis, a wealth of opportunities in our pipeline, and partnerships with industry leaders worldwide, Celdara Medical navigates the path from science to medicine, accelerating innovation to improve human health.